Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

1.

Adenosine augmentation ameliorates psychotic and cognitive endophenotypes of schizophrenia.

Shen HY, Singer P, Lytle N, Wei CJ, Lan JQ, Williams-Karnesky RL, Chen JF, Yee BK, Boison D.

J Clin Invest. 2012 Jul 2;122(7):2567-77. doi: 10.1172/JCI62378. Epub 2012 Jun 18.

PMID:
22706302
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy.

Boison D, Singer P, Shen HY, Feldon J, Yee BK.

Neuropharmacology. 2012 Mar;62(3):1527-43. doi: 10.1016/j.neuropharm.2011.01.048. Epub 2011 Feb 17. Review.

PMID:
21315743
[PubMed - indexed for MEDLINE]
Free PMC Article
3.
4.

Adenosine dysfunction in epilepsy.

Boison D.

Glia. 2012 Aug;60(8):1234-43. doi: 10.1002/glia.22285. Epub 2011 Dec 22. Review.

PMID:
22700220
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Modulators of nucleoside metabolism in the therapy of brain diseases.

Boison D.

Curr Top Med Chem. 2011;11(8):1068-86. Review.

PMID:
21401494
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The adenosine kinase hypothesis of epileptogenesis.

Boison D.

Prog Neurobiol. 2008 Mar;84(3):249-62. doi: 10.1016/j.pneurobio.2007.12.002. Epub 2007 Dec 23. Review.

PMID:
18249058
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Treating impaired cognition in schizophrenia.

Ibrahim HM, Tamminga CA.

Curr Pharm Biotechnol. 2012 Jun;13(8):1587-94. Review.

PMID:
22283754
[PubMed - indexed for MEDLINE]
8.

Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics.

Sumiyoshi T, Bubenikova-Valesova V, Horacek J, Bert B.

Adv Ther. 2008 Oct;25(10):1037-56. doi: 10.1007/s12325-008-0102-2. Review.

PMID:
18839076
[PubMed - indexed for MEDLINE]
9.

Potential role of adenosine A2A receptors in the treatment of schizophrenia.

Wardas J.

Front Biosci. 2008 May 1;13:4071-96. Review.

PMID:
18508501
[PubMed - indexed for MEDLINE]
10.

Role of adenosine in status epilepticus: a potential new target?

Boison D.

Epilepsia. 2013 Sep;54 Suppl 6:20-2. doi: 10.1111/epi.12268. Review.

PMID:
24001064
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Developing treatments for impaired cognition in schizophrenia.

Minzenberg MJ, Carter CS.

Trends Cogn Sci. 2012 Jan;16(1):35-42. doi: 10.1016/j.tics.2011.11.017. Epub 2011 Dec 16. Review.

PMID:
22178120
[PubMed - indexed for MEDLINE]
12.

The hippocampal formation in schizophrenia.

Tamminga CA, Stan AD, Wagner AD.

Am J Psychiatry. 2010 Oct;167(10):1178-93. doi: 10.1176/appi.ajp.2010.09081187. Epub 2010 Sep 1. Review.

PMID:
20810471
[PubMed - indexed for MEDLINE]
13.

Structural cerebral variations as useful endophenotypes in schizophrenia: do they help construct "extended endophenotypes"?

Prasad KM, Keshavan MS.

Schizophr Bull. 2008 Jul;34(4):774-90. doi: 10.1093/schbul/sbn017. Epub 2008 Apr 11. Review.

PMID:
18408230
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Modeling cognitive endophenotypes of schizophrenia in mice.

Kellendonk C, Simpson EH, Kandel ER.

Trends Neurosci. 2009 Jun;32(6):347-58. doi: 10.1016/j.tins.2009.02.003. Epub 2009 May 4. Review.

PMID:
19409625
[PubMed - indexed for MEDLINE]
15.

[Schizophrenia, genetics and cognition].

Belzeaux R, Ibrahim EC, Fakra E, Adida M, Cermolacce M, Azorin JM.

Encephale. 2011 Dec;37 Suppl 2:S127-32. doi: 10.1016/S0013-7006(11)70039-2. Review. French.

PMID:
22212842
[PubMed - indexed for MEDLINE]
16.

Implications for atypical antipsychotics in the treatment of schizophrenia: neurocognition effects and a neuroprotective hypothesis.

Jann MW.

Pharmacotherapy. 2004 Dec;24(12):1759-83. Review.

PMID:
15585443
[PubMed - indexed for MEDLINE]
17.

Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.

Houthoofd SA, Morrens M, Sabbe BG.

Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014. Review.

PMID:
18840365
[PubMed - indexed for MEDLINE]
18.

First- and second-generation antipsychotic medication and cognitive processing in schizophrenia.

Weickert TW, Goldberg TE.

Curr Psychiatry Rep. 2005 Aug;7(4):304-10. Review.

PMID:
16098285
[PubMed - indexed for MEDLINE]
19.

Animal models of schizophrenia.

Jones CA, Watson DJ, Fone KC.

Br J Pharmacol. 2011 Oct;164(4):1162-94. doi: 10.1111/j.1476-5381.2011.01386.x. Review.

PMID:
21449915
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Cognition in mouse models of schizophrenia susceptibility genes.

Arguello PA, Gogos JA.

Schizophr Bull. 2010 Mar;36(2):289-300. doi: 10.1093/schbul/sbp153. Epub 2009 Dec 21. Review.

PMID:
20026558
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk